Internal mammary nodes metastases for breast cancer: whether the morphological verification is necessary?


Cite item

Full Text

Abstract

Background. Metastatic involvement of the internal mammary chain lymph nodes (IMN) is associated with poor prognosis for breast cancer (BC) patients. However, parasternal radiation therapy is still a subject for debate. Methods. Results of 1144 consecutively treated patients with primary BC, who underwent one-stage videothoracoscopic (VATS) parasternal lymphadenectomy from 1998 to 2009, were retrospectively studied. Results. Surgical complications associated with thoracoscopic procedure did not exceed 2%. IMN metastases were detected in 211 (18.4%) patients, 6.0% of these cases did not have axillary invasion. In a wide analysis, the frequency of metastasis was statistically more influenced by: tumor localization (different from external quadrants), primary tumor size (T), level of involved axillary lymph nodes (N) and lymphovascular invasion. Patients with IMN metastases showed significantly poorer long-term outcomes: 5-year overall - OS and disease-free survival - DFS (OS 79.0±3.1% vs 91.4±1.0%, p<0.001; DFS 69.0±3.4% vs 86.0±1.2%, p<0.001, respectively) both in the whole group and in the subgroups with and without axillary lymph node metastases. IMN metastases along with tumor size and axillary nodes showed a negative independent prognostic influence on the DFS and OS (hazard ratio 2.24 [1.45-3.46]; 2.50 [1.41-4.43], respectively). Conclusions. IMN status is an important criterion which may influence on the prognosis and adjuvant treatment strategy in BC. Our study is in favor of conducting randomized clinical studies supporting the impact of radiotherapy treatment for involved IMN.

About the authors

A V Trigolosov

N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation

Email: trigolosov@mail.ru
канд. мед. наук, ст. науч. сотр. отд-ния радиохирургии ФГБУ «РОНЦ им. Н.Н.Блохина» 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

V A Uimanov

N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation

д-р мед. наук, ст. науч. сотр. отд-ния радиохирургии ФГБУ «РОНЦ им. Н.Н.Блохина» 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

M V Chernikh

N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation

канд. мед. наук, науч. сотр. отд-ния радиохирургии ФГБУ «РОНЦ им. Н.Н.Блохина» 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

A V Petrovskiy

N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation

канд. мед. наук, ст. науч. сотр. отд-ния радиохирургии ФГБУ «РОНЦ им. Н.Н.Блохина» 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

E A Nikitina

N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation

аспирант отд-ния радиохирургии ФГБУ «РОНЦ им. Н.Н.Блохина» 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

M I Nechushkin

N.N.Blokhin Russian Cancer Research Center of the Ministry of Health of the Russian Federation

д-р мед. наук, проф., вед. науч. сотр. отд-ния радиохирургии ФГБУ «РОНЦ им. Н.Н.Блохина» 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

References

  1. Taghian A, Jagsi R, Makris A et al. Results of a survey regarding irradiation of internal mammary chain in patients with breast cancer: Practice is culture driven rather than evidence based. Int J Radiat Oncol Biol Phys 2004; 60: 706-14.
  2. Coates S, Winer E.P, Goldhirsch A et al. Tailoring therapies - improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. Ann Oncol 2015; 26 (8): 1533-46.
  3. NCCN Clinical Practice Guidelines in Oncology. Breast cancer. v. 2.2016// http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf
  4. Senkus E, Kyriakides S, Ohno S et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow - up. Ann Oncol 2015; 26 (5): 8-30.
  5. Dutch national guideline for the treatment of breast cancer, v. 2.0; http://www.oncoline.nl/mammacarcinoom
  6. Chang J.S, Park W, Kim Y.B et al. Long - term survival outcomes following internal mammary node irradiation in stage II-III breast cancer: results of a large retrospective study with 12-year follow - up. Int J Radiat Oncol Biol Phys 2013; 86 (5): 867-72.
  7. Hennequin C, Bossard N, Servagi-Vernat S et al. Ten - year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy. Int J Radiat Oncol Biol Phys 2013; 86 (5): 860-6.
  8. Overgaard M. Evaluation of radiotherapy in high risk breast cancer patients given adjuvant systemic therapy. A 25-year update of the Danish breast cancer cooperative group DBCG 82B&C trial. Radiother Oncol 2011; 99 (1): S81.
  9. Ragaz J, Olivotto I.A, Spinelli J.J et al. Locoregional radiation therapy in patients with high - risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005; 97: 116-26.
  10. Clarke M, Collins R, Darby S et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomized trials. Lancet 2005; 366: 2087-106.
  11. EBCTCG (Early Breast Cancer Trialists' Collaborative Group). Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta - analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 2014; 383 (9935): 2127-35.
  12. Estourgie S.H, Tanis P.J, Nieweg O.E et al. Should the hunt for internal mammary chain sentinel nodes begin? An evaluation of 150 breast cancer patients. Ann Surg Oncol 2004; 10 (8): 935-41.
  13. Leidenius M.H.K, Krogerus L.A, Toivonen T.S et al. The clinical value of parasternal sentinel node biopsy in breast cancer. Ann Surg Oncol 2006; 13 (3): 321-6.
  14. Madsen E, Gobardhan P, Bongers V et al. The impact on post - surgical treatment of sentinel lymph node biopsy of internal mammary lymph nodes in patients with breast cancer. Ann Surg Oncol 2007; 14 (4): 1486-92.
  15. Veronesi U, Arnone P, Veronesi P. The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large series. Ann Oncol 2008; 19: 1553-60.
  16. Bourre J.C, Payan R, Collomb D et al. Can the sentinel lymph node technique affect decisions to offer internal mammary chain irradiation? Eur J Nucl Med Mol Imag 2009; 36 (5): 758-64.
  17. Coombs N.J, Boyages J, French J.R et al. Internal mammary sentinel nodes: ignore, irradiate or operate? Eur J Cancer 2009; 45 (5): 789-94.
  18. Heuts E.M, Van der Ent F.W.C, Von Meyenfeldt M.F, Voogd A.C. Internal mammary lymph drainage and sentinel node biopsy in breast cancer - A study on 1008 patients. Eur J Surg Oncol 2009; 35: 252-7.
  19. Postma E.L, van Wieringen S, Hobbelink M.G et al. Sentinel lymph node biopsy of the internal mammary chain in breast cancer. Breast Cancer Res Treat 2012; 134 (2): 735-41.
  20. Gnerlich J.L, Barreto-Andrade J.C, Czechura T et al. Accurate Staging with Internal Mammary Chain Sentinel Node Biopsy for Breast Cancer. Ann Surg Oncol 2014; 21 (2): 368-74.
  21. Caudle A.S, Yi M, Hoffman K.E et al. Impact of Identification of Internal Mammary Sentinel Lymph Node Metastasis in Breast Cancer Patients. Ann Surg Oncol 2014; 21 (1): 60-5.
  22. Poortmans P.M, Collette S, Kirkove C et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med 2015; 373: 317-27.
  23. Whelan T.J, Olivotto I.A, Parulekar W.R et al. Regional nodal irradiation in early - stage breast cancer. N Engl J Med 2015; 373: 307-16.
  24. Thorsen L.B.J, Thomsen M.S, Berg M et al. CT-planned internal mammary node radiotherapy in the DBCG-IMN study: benefit versus potentially harmful effects. Acta Oncol 2014; 53: 1027-34.
  25. Thorsen L.B.J, Offersen B.V, Dano H et al. DBCG-IMN: A population - based cohort study on the effect of internal mammary node irradiation in early node - positive breast cancer. J Clin Oncol 2016; 34: 314-20.

Copyright (c) 2017 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies